Correlation Between Abivax SA and OSE Pharma
Can any of the company-specific risk be diversified away by investing in both Abivax SA and OSE Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abivax SA and OSE Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abivax SA and OSE Pharma SA, you can compare the effects of market volatilities on Abivax SA and OSE Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abivax SA with a short position of OSE Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abivax SA and OSE Pharma.
Diversification Opportunities for Abivax SA and OSE Pharma
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Abivax and OSE is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Abivax SA and OSE Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OSE Pharma SA and Abivax SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abivax SA are associated (or correlated) with OSE Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OSE Pharma SA has no effect on the direction of Abivax SA i.e., Abivax SA and OSE Pharma go up and down completely randomly.
Pair Corralation between Abivax SA and OSE Pharma
Assuming the 90 days trading horizon Abivax SA is expected to under-perform the OSE Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Abivax SA is 1.41 times less risky than OSE Pharma. The stock trades about -0.36 of its potential returns per unit of risk. The OSE Pharma SA is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest 926.00 in OSE Pharma SA on September 14, 2024 and sell it today you would lose (105.00) from holding OSE Pharma SA or give up 11.34% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Abivax SA vs. OSE Pharma SA
Performance |
Timeline |
Abivax SA |
OSE Pharma SA |
Abivax SA and OSE Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abivax SA and OSE Pharma
The main advantage of trading using opposite Abivax SA and OSE Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abivax SA position performs unexpectedly, OSE Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OSE Pharma will offset losses from the drop in OSE Pharma's long position.Abivax SA vs. Gensight Biologics SA | Abivax SA vs. Innate Pharma | Abivax SA vs. Poxel SA | Abivax SA vs. Nanobiotix SA |
OSE Pharma vs. Innate Pharma | OSE Pharma vs. Quantum Genomics SA | OSE Pharma vs. Valneva SE | OSE Pharma vs. Poxel SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |